Reduce Cardiovascular Risk With Tirzepatide
8 Jul 2024 · 1 min

0:42
Dr. Charles Mok explains how tirzepatide reduces cardiovascular death risk in people with heart disease or diabetes. He suggests overweight patients may need it long-term and recommends cycling the drug on and off, three months on then a break, to prevent tolerance and keep weight loss working.
Questions this video answers
Dr. Charles Mok.
Cycles of three months on, then a short break (a few weeks to a couple months), then three months on again.
Long-term health benefits including statistically reduced cardiovascular mortality.










